Zolla-Pazner; Susan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zolla-Pazner; Susan.The latest application filed is for "immunogenic polypeptides".

Company Profile

1.15.15

Zolla-Pazner; Susan - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunogenic polypeptides Grant 10,568,969 - Totrov , et al. Feb	2020-02-25
Immunogenic Polypeptides App 20180071400 - TOTROV; Maxim ; et al.	2018-03-15
Peptides Mimicking Hiv-1 Viral Epitopes In The V2 Loop For The Gp120 Surface Envelope Glycoprotein App 20170190764 - CARDOZO; Timothy ; et al.	2017-07-06
Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein Grant 9,611,294 - Cardozo , et al. April 4, 2	2017-04-04
Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide Grant 9,534,020 - Cardozo , et al. January 3, 2	2017-01-03
Immunodominant Mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization Grant 9,335,325 - Laal , et al. May 10, 2	2016-05-10
Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies Grant 8,961,987 - Zolla-Pazner , et al. February 24, 2	2015-02-24
Immunogenic Polypeptides Having An Immunogenic Scaffold Protein And A Loop Peptide, Presenting A 3074- Or 2219/2557- Monoclonal Antibody-targeted Epitope, Which Is Present In The Hiv Gp120 Protein App 20130287804 - Cardozo; Timothy ; et al.	2013-10-31
Peptides Mimicking Hiv-1 Viral Epitopes In The V2 Loop For The Gp120 Surface Envelope Glycoprotein App 20130071424 - CARDOZO; Timothy ; et al.	2013-03-21
Immunodominant Mycobacterium Tuberculosis Peptides From Cell Wall Proteins For Early Diagnosis And Immunization App 20110104194 - Laal; Suman ; et al.	2011-05-05
Recombinant HIV-1 gp120 immunogen with three different V3 loops from viruses of different clades Grant 7,847,085 - Zolla-Pazner , et al. December 7, 2	2010-12-07
Constrained Hiv V3 Loop Peptides As Novel Immunogens And Receptor Antagonists App 20100278853 - Anglister; Jacob ; et al.	2010-11-04
Early detection of mycobacterial disease using peptides Grant 7,807,182 - Laal , et al. October 5, 2	2010-10-05
Mycobacterial proteins as early antigens for serodiagnosis and vaccines Grant 7,745,141 - Laal , et al. June 29, 2	2010-06-29
Method for determining co-receptor selectivity of Human Immunodeficiency Virus-1 Grant 7,638,319 - Cardozo , et al. December 29, 2	2009-12-29
Early detection of mycobacterial disease using peptides App 20090280140 - Laal; Suman ; et al.	2009-11-12
Immunogen Presenting Hiv Gp120 V3 Loop In A Conformation That Induces Broadly Neutralizing Antibodies App 20090098144 - ZOLLA-PAZNER; Susan ; et al.	2009-04-16
INDUCTION OF BROADLY REACTIVE NEUTRALIZING ANTIBODIES BY FOCUSING THE IMMUNE RESPONSE ON V3 EPITOPES OF THE HIV-1 gp120 ENVELOPE App 20080279879 - Zolla-Pazner; Susan	2008-11-13
Constrained Hiv V3 Loop Peptides as Novel Immunogens and Receptor Antagonists App 20080206264 - Anglister; Jacob ; et al.	2008-08-28
Recombinant HIV-1 gp120 Immunogen with Three Different V3 Loops from Viruses of Different Clades App 20080095791 - Zolla-Pazner; Susan ; et al.	2008-04-24
Method for determining co-receptor selectivity of human immunodeficiency virus-1 App 20070072200 - Cardozo; Timothy ; et al.	2007-03-29
Mycobacterial proteins as early antigens for serodiagnosis and vaccines App 20050084904 - Laal, Suman ; et al.	2005-04-21
Early detection of mycobacterial disease Grant 6,506,384 - Laal , et al. January 14, 2	2003-01-14
Human monoclonal antibodies to human immunodeficiency virus Grant 5,731,189 - Zolla-Pazner , et al. March 24, 1	1998-03-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.